INDV — INDIVIOR PHARMACEUTICALS INC
As of Q2 2026, 35 SEC-registered investment managers reported holding INDV (INDIVIOR PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $2.02B across 50.13M shares. That is +0.9% by share count (+469.17K shares) versus the previous quarter, while reported value moved +33.7%. Ownership is concentrated: the five largest holders account for 63.9% of reported value and the top ten for 81.3%.
Compared with the prior quarter, 2 opened new positions, 19 added to existing stakes, 14 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
INDV is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 18.71M | $767.65M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 5.47M | $196.40M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 3.40M | $139.33M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 3.32M | $136.07M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 3.16M | $129.68M | 0.01% | Add |
| Citadel Advisors history | Q2 2026 | 2.87M | $117.72M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 2.10M | $86.12M | 0.03% | Reduce |
| Invesco Ltd history | Q2 2026 | 1.84M | $75.62M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 1.68M | $68.96M | 0.01% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 1.64M | $67.37M | 0.03% | Reduce |
| Point72 Asset Management history | Q2 2026 | 1.25M | $51.31M | 0.06% | Add |
| Northern Trust Corp history | Q2 2026 | 1.24M | $50.95M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.22M | $50.25M | 0.01% | Add |
| Soros Fund Management history | Q4 2025 | 1.15M | $41.42M | 0.54% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 2.34M | $36.69M | 0.01% | Reduce |
| Principal Global Investors history | Q2 2026 | 772.17K | $31.68M | 0.02% | Add |
| BNY Mellon history | Q2 2026 | 744.07K | $30.53M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 696.27K | $28.57M | 0.00% | Reduce |
| Capital World Investors history | Q3 2023 | 1.28M | $27.80M | 0.01% | Hold |
| Citigroup Inc history | Q2 2026 | 643.01K | $26.38M | 0.01% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 269.60K sh · $11.34M
- Amundi US 9.65K sh · $395.82K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 49.45K sh · $1.51M
- Royce & Associates sold 9.90K sh · $301.75K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | 103.64K | 67.58K | 5.68M | 8.73M | 18.23M | 18.54M | 18.71M |
| Morgan Stanley | 1.84K | 5.74K | 5.91K | 198.25K | 143.59K | 5.22M | 3.54M | 713.18K | 567.27K | 5.62M | 4.38M | 3.51M | 3.40M |
| Franklin Resources | — | — | — | — | — | — | — | — | — | 58.11K | 102.72K | 111.59K | 3.32M |
| Geode Capital Management | 104.60K | 106.89K | 108.03K | 114.63K | 122.74K | 132.24K | 128.88K | 128.98K | 1.58M | 2.86M | 2.84M | 2.93M | 3.16M |
| Citadel Advisors | — | — | — | 92.50K | 122.54K | 346.49K | 476.80K | 85.83K | 76.05K | 2.79M | 3.20M | 3.71M | 2.87M |
| Millennium Management | — | — | — | 333.03K | 493.31K | 900.83K | 1.23M | 2.55M | 3.50M | 2.31M | 2.49M | 4.60M | 2.10M |
| Invesco Ltd | — | — | — | — | — | — | — | — | — | 76.54K | 286.69K | 1.56M | 1.84M |
| UBS Group AG | 826.31K | 480.57K | 826.13K | 1.48M | 1.80M | 842.13K | 832.81K | 3.53M | 2.39M | 793.76K | 788.57K | 2.19M | 1.68M |
| Arrowstreet Capital | 457.76K | 334.54K | 42.66K | 327.15K | 179.50K | — | — | — | — | — | 1.71M | 2.32M | 1.64M |
| Point72 Asset Management | — | — | — | — | — | — | — | 1.89M | 3.57M | 2.86M | 1.82M | 94.94K | 1.25M |
| Northern Trust Corp | — | — | — | — | — | — | — | — | 735.16K | 1.01M | 1.09M | 1.16M | 1.24M |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | 307.56K | 1.15M | 1.24M | 1.14M | 1.22M |
| Principal Global Investors | — | — | — | — | — | — | — | — | — | 70.36K | 693.29K | 767.38K | 772.17K |
| BNY Mellon | — | — | — | — | 11.67K | — | — | — | 310.64K | 349.43K | 700.27K | 682.78K | 744.07K |
| Goldman Sachs Group | 3.52M | 5.68M | 4.46M | 4.66M | 1.40M | 4.95M | 7.07M | 8.37M | 9.56M | 6.65M | 3.25M | 2.41M | 696.27K |
| Citigroup Inc | 213.43K | 153.77K | 323.46K | 267.39K | 224.75K | 244.90K | 996.33K | 136.46K | 198.36K | 36.98K | 92.05K | 54.48K | 643.01K |
| Bank of America Corp | 2.39M | 2.70M | 2.63M | 2.48M | 4.06M | 1.65M | 1.25M | 390.72K | 486.92K | 331.81K | 804.24K | 667.13K | 632.97K |
| PSP Investments | — | — | — | — | — | — | — | — | — | — | 432.10K | 446.64K | 418.88K |
| Fidelity Management & Research (FMR) | 3.58M | 5.50M | 5.10M | 6.23M | 6.54M | 560 | 205 | — | 310 | 69.45K | 496.64K | 527.71K | 402.42K |
| Wells Fargo & Co | 1.47K | 1.43K | 1.42K | 1.42K | 1.09K | 1.27K | 1.56K | 1.18K | 67.29K | 432.46K | 679.97K | 290.84K | 337.63K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details